DEMAREE JOHN 4
4 · Karyopharm Therapeutics Inc. · Filed Aug 27, 2020
Insider Transaction Report
Form 4
DEMAREE JOHN
Chief Commercial Officer
Transactions
- Purchase
Common Stock
2020-08-26$14.54/sh+7,500$109,013→ 7,500 total
4 · Karyopharm Therapeutics Inc. · Filed Aug 27, 2020
Common Stock